Allergy and Ashthma in Children Who Were Fed Supplemented Infant Formula

This study has been completed.
Sponsor:
Information provided by:
Mead Johnson Nutrition
ClinicalTrials.gov Identifier:
NCT01205659
First received: September 17, 2010
Last updated: NA
Last verified: September 2010
History: No changes posted
  Purpose

Allergy and Asthma study of children (3 - 7 Years of age) who participated in randomized trials of supplemented infant formula during infancy conducted by The Retina Foundation of the Southwest .


Condition
Allergy and Asthma

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Allergy and Asthma in Children Who Were Fed Supplemented Infant Formula (3-7 Years of Age)

Resource links provided by NLM:


Further study details as provided by Mead Johnson Nutrition:

Primary Outcome Measures:
  • Prevalence of asthma and allergy related diagnosis in medical records for ages 3 - 7 years

Secondary Outcome Measures:
  • Prevalence of Serious Adverse Events in medical records
  • Long-term growth

Study Start Date: December 2008
Study Completion Date: December 2009
Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   3 Years to 7 Years
Genders Eligible for Study:   Both
Sampling Method:   Probability Sample
Study Population

Children who participated in randomizaed trials of supplemented infant formula conducted by The Retina Foundation of the Southwest during infancy

Criteria

Inclusion Criteria:

  • Children who participated in randomized trials of supplemented infant formula conducted by The Retina Foundation of the Southwest during infancy

Exclusion Criteria:

-

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01205659

Locations
United States, Texas
The Retina Foundation of The Southwest
Dallas, Texas, United States, 75231
Sponsors and Collaborators
Mead Johnson Nutrition
  More Information

No publications provided

Responsible Party: Eileen Birch, The Retina Foundation of the Southwest
ClinicalTrials.gov Identifier: NCT01205659     History of Changes
Other Study ID Numbers: 8611
Study First Received: September 17, 2010
Last Updated: September 17, 2010
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Hypersensitivity
Asthma
Immune System Diseases
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate

ClinicalTrials.gov processed this record on April 17, 2014